Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Published Online: 2021-10-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Alex Martinez-Marti•Alexander Luft•Andrey Akopov•Antonio Chella•Barbara Gitlitz•Caicun Zhou•David Voong•Elizabeth Bennett•Enriqueta Felip•Fan Wu•Heather Wakelee•Hirotsugu Kenmotsu•Ihor Vynnychenko•Jing Yi•Mark McCleland•Nasser Altorki•Oleksandr Goloborodko•Shunichi Sugawara•Tibor Csőszi•Yu Deng•Yuh-Min Chen
